Form 8-K - Current report:
SEC Accession No. 0001140361-24-049137
Filing Date
2024-12-12
Accepted
2024-12-12 16:02:43
Documents
16
Period of Report
2024-12-09
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K ny20039717x4_8k.htm   iXBRL 8-K 35359
2 EXHIBIT 1.1 ny20039717x4_ex1-1.htm EX-1.1 309804
3 EXHIBIT 5.1 ny20039717x4_ex5-1.htm EX-5.1 14933
7 ny20039717x4_ex5-1img01.jpg GRAPHIC 2262
  Complete submission text file 0001140361-24-049137.txt   574408

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA rckt-20241209.xsd EX-101.SCH 3995
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE rckt-20241209_lab.xml EX-101.LAB 21967
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rckt-20241209_pre.xml EX-101.PRE 16053
19 EXTRACTED XBRL INSTANCE DOCUMENT ny20039717x4_8k_htm.xml XML 4057
Mailing Address 350 FIFTH AVENUE SUITE 7530 NEW YORK NY 10118
Business Address 350 FIFTH AVENUE SUITE 7530 NEW YORK NY 10118 646-440-9100
ROCKET PHARMACEUTICALS, INC. (Filer) CIK: 0001281895 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36829 | Film No.: 241544790
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)